These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34579635)

  • 1. A Review on Coumarin Derivatives as Potent Anti-tuberculosis Agents.
    Mujeeb S; Singh K; Yogi B; Ansari V; Sinha S
    Mini Rev Med Chem; 2022; 22(7):1064-1080. PubMed ID: 34579635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity.
    Reddy DS; Kongot M; Kumar A
    Tuberculosis (Edinb); 2021 Mar; 127():102050. PubMed ID: 33540334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments of coumarin-containing derivatives and their anti-tubercular activity.
    Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS
    Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coumarin as a Privileged and Medicinally Important Scaffold in the Treatment of Tuberculosis.
    Gupta V; Ambatwar R; Bhanwala N; Khatik GL
    Curr Top Med Chem; 2023; 23(16):1489-1502. PubMed ID: 37005527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of natural and synthetic coumarin derivatives against
    Pires CT; Scodro RB; Cortez DA; Brenzan MA; Siqueira VL; Caleffi-Ferracioli KR; Vieira LC; Monteiro JL; Corrêa AG; Cardoso RF
    Future Med Chem; 2020 Sep; 12(17):1533-1546. PubMed ID: 32820960
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Insights into the Chemistry and Antitubercular Potential of Benzimidazole and Imidazole Derivatives.
    Parwani D; Bhattacharya S; Rathore A; Mallick C; Asati V; Agarwal S; Rajoriya V; Das R; Kashaw SK
    Mini Rev Med Chem; 2021; 21(5):643-657. PubMed ID: 33138762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.
    Kawate T; Iwase N; Shimizu M; Stanley SA; Wellington S; Kazyanskaya E; Hung DT
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6052-9. PubMed ID: 24103299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tuberculosis lead molecules from natural products targeting Mycobacterium tuberculosis ClpC1.
    Lee H; Suh JW
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):205-12. PubMed ID: 26586403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DFT based QSAR/QSPR models in the development of novel anti-tuberculosis drugs targeting Mycobacterium tuberculosis.
    Rajkhowa S; Deka RC
    Curr Pharm Des; 2014; 20(27):4455-73. PubMed ID: 24245759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, molecular docking, and biological evaluation of coumarin-thymidine analogs as potent anti-TB agents.
    Reddy DS; Sinha A; Kurjogi MM; Shanavaz H; Kumar A
    Arch Pharm (Weinheim); 2023 May; 356(5):e2200633. PubMed ID: 36634969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of coumarin derivatives in pharmacotherapy of breast cancer.
    Musa MA; Cooperwood JS; Khan MO
    Curr Med Chem; 2008; 15(26):2664-79. PubMed ID: 18991629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
    Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS
    Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches.
    Bueno RV; Braga RC; Segretti ND; Ferreira EI; Trossini GH; Andrade CH
    Curr Pharm Des; 2014; 20(27):4474-85. PubMed ID: 24245758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Journey and Recent Advances in the Synthesis of Coumarin Derivatives.
    Sinha S; Singh K; Ved A; Hasan SM; Mujeeb S
    Mini Rev Med Chem; 2022; 22(9):1314-1330. PubMed ID: 34784861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of marine natural Products: Recent Advances in the discovery of Anti-Tuberculosis agents.
    Peng X; Zeng Z; Hassan S; Xue Y
    Bioorg Chem; 2024 Oct; 151():107699. PubMed ID: 39128242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship.
    Keri RS; Budagumpi S; Balappa Somappa S
    J Clin Pharm Ther; 2022 Jul; 47(7):915-931. PubMed ID: 35288962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.